Studies have shown that METTL3 is highly expressed in NSCLC and promotes the occurrence and development of NSCLC by promoting tumor cell proliferation, EMT, invasion, metastasis, angiogenesis, and anti-apoptosis. This evidence concerns the gene METTL3 and neoplasm.